S‐palmitoylation has emerged as a key regulatory mechanism in various physiological and pathological processes, particularly in cancer progression, where it modulates the functions of oncogenes and signalling proteins, including PD‐L1, EGFR, NRAS and HRAS [6, 7]. This evidence concerns the gene CD274 and cancer.